Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6 USD | -4.78% | -11.16% | -52.00% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Clinical Lab
62.0
%
| 3 | 16.2 % | 3 | 62.0 % | +8.03% |
Over-the-counter
21.9
%
| 1 | 5.8 % | 1 | 21.9 % | +7.35% |
Contract Manufacturing
11.4
%
| 0 | 2.4 % | 1 | 11.4 % | +32.90% |
Physicians' Office
4.7
%
| 14 | 75.6 % | 0 | 4.7 % | -98.25% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Asia
37.9
%
| 13 | 70.9 % | 2 | 37.9 % | -84.89% |
Europe
33.7
%
| 4 | 23.0 % | 2 | 33.7 % | -58.56% |
North America
27.5
%
| 1 | 5.3 % | 1 | 27.5 % | +47.44% |
Middle East
0.7
%
| 0 | 0.4 % | 0 | 0.7 % | -44.29% |
South America
0.2
%
| 0 | 0.5 % | 0 | 0.2 % | -87.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zackary Irani
CEO | Chief Executive Officer | 58 | 01/86/01 |
Gary Lu
DFI | Director of Finance/CFO | 43 | 01/23/01 |
Robert Carlson
PRN | Corporate Officer/Principal | - | 30/22/30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Zackary Irani
CEO | Chief Executive Officer | 58 | 01/86/01 |
Allen Barbieri
BRD | Director/Board Member | 65 | 01/99/01 |
Jane Emerson
BRD | Director/Board Member | 70 | 01/07/01 |
David Moatazedi
BRD | Director/Board Member | 46 | 07/22/07 |
John Kenny
CHM | Chairman | 54 | 25/23/25 |
Catherine Coste
BRD | Director/Board Member | 58 | 03/20/03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 16,821,646 | 15,592,969 ( 92.70 %) | 0 | 92.70 % |
Company contact information
Sector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-52.00% | 10.6M | |
-3.77% | 184B | |
-1.77% | 107B | |
-1.43% | 67.52B | |
+2.06% | 50.06B | |
+9.43% | 45.67B | |
+3.40% | 41B | |
+3.04% | 26.73B | |
+4.64% | 26.47B | |
+15.23% | 25.05B |
- Stock Market
- Equities
- BMRA Stock
- Company Biomerica, Inc.